- 专利标题: ALKALIZED ORGANIC PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION
-
申请号: US17828573申请日: 2022-05-31
-
公开(公告)号: US20220288126A1公开(公告)日: 2022-09-15
- 发明人: Jeffrey M. Golini
- 申请人: Jeffrey M. Golini
- 申请人地址: US MT Billings
- 专利权人: Jeffrey M. Golini
- 当前专利权人: Jeffrey M. Golini
- 当前专利权人地址: US MT Billings
- 主分类号: A61K35/20
- IPC分类号: A61K35/20 ; A23L5/00 ; A23L33/125 ; A61K31/198 ; A61K31/337 ; A61K36/185 ; A61K36/90 ; A61K45/06 ; A23L29/30 ; A23L33/105 ; A23L33/115 ; A23L33/15 ; A23L33/175 ; A23L33/00 ; A23L33/16 ; A23L33/185 ; A23L33/19 ; A61K36/889 ; A61K31/718 ; A61K33/00 ; A61K33/42 ; A61K31/661 ; A61K36/899 ; A61K38/16
摘要:
The invention relates to a pharmaceutical or nutraceutical composition comprising an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof. Such compositions are useful for treating a range of diseases and conditions. They also give rise to beneficial physiological effects such as, for example, increasing physical strength, muscle mass and endurance.
公开/授权文献
信息查询